A Neonatal Erythropoietin and Therapeutic Hypothermia Outcomes (NEATO) Phase II study by Mulkey et al. 2017 [125] (Table 4) was carried out in seven US centers on 50 newborn infants with moderate to severe HIE. This evidence concerns the gene EPO and perinatal asphyxia.